PHR (Phreesia) ROCE %: 5.65% (As of Apr. 2026)


PHR Phreesia Inc PHR
65 GF Score
Price $9.59
GF Value $26.97
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Phreesia ROCE %?

Phreesia PHR +4.81% 65 ROCE % is 5.65% as of Apr. 2026. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $26.97 (Possible Value Trap). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Phreesia's annualized ROCE % for the quarter that ended in Apr. 2026 was 5.65%.

Phreesia  (NYSE:PHR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Phreesia ROCE % Related Terms

Phreesia ROCE % Historical Data

* Premium members only.

The historical data trend for Phreesia's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phreesia ROCE % Chart

Phreesia Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROCE %
Get a 7-Day Free Trial Premium Member Only -33.49 -48.60 -48.43 -20.00 -0.53

Phreesia Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.89 -0.23 6.93 -4.49 5.65
PHR
65GF Score
Phreesia Inc PHR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phreesia ROCE % Calculation

Phreesia's annualized ROCE % for the fiscal year that ended in Jan. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=-1.987/( ( (388.415 - 114.023) + (663.79 - 183.241) )/ 2 )
=-1.987/( (274.392+480.549)/ 2 )
=-1.987/377.4705
=-0.53 %

Phreesia's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=28.088/( ( (663.79 - 183.241) + (666.141 - 152.109) )/ 2 )
=28.088/( ( 480.549 + 514.032 )/ 2 )
=28.088/497.2905
=5.65 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.65% mean?
Phreesia (PHR) has a ROCE % of 5.65% as of Apr. 2026.
Is Phreesia's ROCE % too high?
Phreesia's current ROCE % is 5.65%. The Healthcare Providers & Services industry median ROCE % is 6.41. Phreesia's value of 5.65% is 11.9% below this industry median. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's ROCE % compare to HSTM and WEAV?
Phreesia's ROCE % of 5.65% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Phreesia's value of 5.65% is 11.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current ROCE % of 5.65% is 11.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current ROCE % is 5.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $26.97, compared to a current price of $9.59 — trading 64.4% below its estimated fair value. The current ROCE % is 5.65% and 11.9% below the Healthcare Providers & Services industry median of 6.41. Phreesia's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Phreesia (PHR), the current ROCE % is 5.65% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phreesia (PHR) Overvalued in 2026?

Based on GuruFocus' analysis, Phreesia stock appears to be undervalued. The current stock price of $9.59 is trading 64.4% below its estimated GF Value™ of $26.97. GuruFocus considers Phreesia to be Possible Value Trap.

Key valuation signals for PHR:

  • ROCE %: 5.65%
  • GF Value™: $26.97 vs. price of $9.59 (64.4% below fair value)
  • GF Score™: 65/100 with 3 warning signs
  • Industry Position: 11.9% below the Healthcare Providers & Services median

No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Phreesia Business Description

Other Exchanges 19P:Germany
Address 1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score

Get the complete analysis for PHR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.59
Price
$26.97
GF Value